We are live on ! Find out more
STRO icon

Sutro Biopharma
STRO

86 hedge funds and large institutions have $304M invested in Sutro Biopharma in 2020 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 40 increasing their positions, 16 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more repeat investments, than reductions

Existing positions increased: 40 | Existing positions reduced: 16

64% more first-time investments, than exits

New positions opened: 18 | Existing positions closed: 11

61% more capital invested

Capital invested by funds: $189M → $304M (+$115M)

8% more funds holding

Funds holding: 80 → 86 (+6)

1.72% more ownership

Funds ownership: 6.79% → 8.51% (+1.7%)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
86
Holders Change
+6
Holders Change %
+7.5%
% of All Funds
1.74%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
18
Increased
40
Reduced
16
Closed
11
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EC
EcoR1 Capital
California
+$12.1M
2
BlackRock
BlackRock
New York
+$10.3M
3
BI
BVF Inc
California
+$6.79M
4
IC
Ikarian Capital
Texas
+$4.61M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$3.88M

Top Sellers

Rank Fund Capital Flow
1
LGM
Logos Global Management
California
-$2.81M
2
Renaissance Technologies
Renaissance Technologies
New York
-$1.16M
3
SCM
Sio Capital Management
New York
-$1.15M
4
Citadel Advisors
Citadel Advisors
Florida
-$486K
5
Bessemer Group
Bessemer Group
New Jersey
-$374K
Name Holding Trade Value Shares
Change 		Change in
Stake
Verition Fund Management
26
Verition Fund Management
Connecticut
$2.07M +$1.94M +20,570 New
Janus Henderson Group
27
Janus Henderson Group
United Kingdom
$1.57M -$67K -709 -4%
GPCM
28
Granite Point Capital Management
Massachusetts
$1.48M -$26.3K -278 -2%
OM
29
Opaleye Management
Massachusetts
$1.47M +$1.38M +14,600 New
Victory Capital Management
30
Victory Capital Management
Texas
$1.42M -$187K -1,974 -12%
IBT
31
International Biotechnology Trust
United Kingdom
$1.4M – – –
Acadian Asset Management
32
Acadian Asset Management
Massachusetts
$1.27M +$315K +3,334 +36%
DCM
33
DAFNA Capital Management
California
$1.2M +$118K +1,250 +12%
N
34
Nuveen
North Carolina
$1.1M +$555K +5,870 +116%
Two Sigma Investments
35
Two Sigma Investments
New York
$1.08M +$1.02M +10,773 New
JP Morgan Chase
36
JP Morgan Chase
New York
$745K -$95K -1,006 -12%
Charles Schwab
37
Charles Schwab
California
$662K +$167K +1,763 +37%
DCM
38
Driehaus Capital Management
Illinois
$659K – – –
HS
39
HighVista Strategies
Massachusetts
$651K +$611K +6,469 New
Nomura Holdings
40
Nomura Holdings
Japan
$620K +$581K +6,150 New
Bank of New York Mellon
41
Bank of New York Mellon
New York
$617K +$108K +1,145 +23%
California Public Employees Retirement System
42
California Public Employees Retirement System
California
$541K +$157K +1,660 +45%
Jacobs Levy Equity Management
43
Jacobs Levy Equity Management
New Jersey
$533K -$91.8K -972 -15%
MAM
44
Martingale Asset Management
Massachusetts
$519K -$312K -3,300 -39%
BFM
45
Boothbay Fund Management
New York
$517K +$486K +5,148 New
SSA
46
Schonfeld Strategic Advisors
New York
$512K +$482K +5,100 New
Wells Fargo
47
Wells Fargo
California
$459K +$142K +1,501 +49%
SFI
48
Susquehanna Fundamental Investments
Pennsylvania
$423K +$398K +4,213 New
Two Sigma Advisers
49
Two Sigma Advisers
New York
$420K +$395K +4,180 New
PAM
50
Panagora Asset Management
Massachusetts
$410K -$7.46K -79 -2%
1
2
3 4

STRO Hedge Fund Activity: Q3 2020 in Review

86 of the 4,956 institutional investors tracked by Wall St. Rank reported a position in Sutro Biopharma (STRO) for Q3 2020, worth a combined $304M — up 61% from $189M a quarter earlier.

Buyers outnumbered sellers: 18 funds opened new STRO positions and 11 closed out — a net gain of 7 holders — while 40 added to existing stakes and 16 trimmed.

The largest buyer was EcoR1 Capital, adding an estimated $12.1M. The largest seller was Logos Global Management, exiting entirely with an estimated $2.81M sold.

  • 86 institutional investors held Sutro Biopharma (STRO) as of Q3 2020, up from 80 in Q2 2020.
  • Funds reported $304M of Sutro Biopharma stock for Q3 2020, up 61% quarter-over-quarter.
  • 18 funds opened new Sutro Biopharma positions in Q3 2020 and 11 closed out, a net change of +7 holders.
  • The largest Sutro Biopharma buyer in Q3 2020 was EcoR1 Capital, an estimated $12.1M added.
  • The largest Sutro Biopharma seller in Q3 2020 was Logos Global Management, an estimated $2.81M sold.

Based on aggregated 13F filings for Q3 2020.